EE267 Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.1866
https://www.valueinhealthjournal.com/article/S1098-3015(25)01995-3/fulltext
Title :
EE267 Cost-Effectiveness of Dostarlimab in the Treatment of Newly Diagnosed Patients with Locally Advanced Rectal Cancer: Early Economic Modelling
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)01995-3&doi=10.1016/j.jval.2025.04.1866
First page :
Section Title :
Open access? :
No
Section Order :
10058